GMP Новости — 2020 — Страница 4 — IX Всероссийская GMP-Конференция

Уфа, Конгресс-холл
Торатау

IX Всероссийская GMP-Конференция

21-23 августа 2024

РЕГИСТРАЦИЯ

УЧАСТНИКАМ

ПРОГРАММА

НОВОСТИ

16 Сен 2021

NOVARTIS IS A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

Novartis is an international pharmaceutical company headquartered in Basel, Switzerland. The company’s subdivisions, factories and research centres are located in different countries throughout the world and incorporate more than 110…

16 Сен 2021

AKRIKHIN TO PARTNER THE VI ALL-RUSSIAN GMP CONFERENCE 2021

AKRIKHIN is one of the leading Russian pharmaceutical companies producing high-quality medicines of therapeutic groups most demanded in Russia: dermatology, cardiology, neurology, gynaecology, pulmonology, endocrinology, and others. The company’s product…

16 Сен 2021

PRO.MED.CS PRAHA A.S. TO SUPPORT A SESSION DEDICATED TO THE CIRCULATION OF PHARMACEUTICALS IN THE EAEU

In 2019, Czech Republic’s leading pharmaceutical company PRO.MED.CS Praha a.s. celebrated its 30th anniversary. Today, this manufacturer supplies products to more than 25 countries, primarily, to the Russian Federation, Central and Eastern…

16 Сен 2021

ABBOTT WILL SUPPORT THE PANEL DISCUSSION “INTERDISCIPLINARY APPROACH TO GOOD PRACTICES REGULATION”.

14 Сен 2021

TEVA TO SHARE ITS PHARMACEUTICAL QUALITY AND SAFETY EXPERT REVIEW

In 2021, Teva in partnership with the 6th All-Russian GMP Conference involving international participants will present its experience and participate in discussions at the St. Petersburg site. Teva is one of…

14 Сен 2021

AMGEN. OUR MISSION: TO SERVE PATIENTS

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools…

14 Сен 2021

PHARMECO GROUP OF COMPANIES IS A SPECIAL PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

Pharmeco GC is a Russian pharmaceutical vertically integrated group of companies operating in all the main segments of the pharmaceutical industry – scientific research and development, production and distribution of…

9 Сен 2021

NOVO NORDISK BECOMES A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

Novo Nordisk is a global pharmaceutical company founded in Denmark in 1923 and the world’s leader in the development and manufacture of drugs for the treatment of diabetes and obesity.…

1 Сен 2021

GEDEON RICHTER STARTS PRODUCING IN RUSSIA AN INNOVATIVE DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER

Gedeon Richter Ltd. launches production of Reagila (cariprazine) for patients suffering schizophrenia and bipolar disorder in Russia. Starting from July 26, 2021, the drug will be produced at the GEDEON…

31 Авг 2021

GMP CONFERENCE ORGANIZERS EXPECTING TO RECEIVE QUESTIONS FROM PHARMACEUTICAL INDUSTRY REPRESENTATIVES RELATED TO TECHNOLOGY TRANSFER

On 24 September 2021, on the third day of the 6th All-Russian GMP Conference with International Participants, traditional master classes will take place, which will allow to gain new knowledge…

25 Сен 2020

30 СЕНТЯБРЯ, В РАМКАХ V ВСЕРОССИЙСКОЙ GMP-КОНФЕРЕНЦИИ С МЕЖДУНАРОДНЫМ УЧАСТИЕМ ПРОЙДЕТ КРУГЛЫЙ СТОЛ «НЕПРЕРЫВНОЕ ПРОИЗВОДСТВО», НА КОТОРОМ С ДОКЛАДОМ ВЫСТУПИТ СОКРАТ КИРИДЗИС, РУКОВОДИТЕЛЬ НАПРАВЛЕНИЯ РАЗРАБОТКИ И РЕГУЛЯТОРНОЙ ПОДДЕРЖКИ ОНКОЛОГИЧЕСКИХ ПРЕПАРАТОВ КОМПАНИИ «НОВАРТИС»

30 сентября, в рамках V Всероссийской GMP-конференции с международным участием пройдет круглый стол «Непрерывное производство», на котором с докладом выступит Сократ Киридзис, Руководитель направления разработки и регуляторной поддержки онкологических препаратов…

22 Сен 2020

LETTER CALENDAR: NEWS OF THE PARTNERS OF THE ALL-RUSSIA GMP CONFERENCE

On Thursday we will take a look at the new of the partners of the All-Russia GMP Conference. One of the most noteworthy events early this autumn was the Forbes…

22 Сен 2020

GLP: TOP QUALITY OF NONCLINICAL STUDIES

Good Laboratory Practice (GLP) is an international standard, which includes a system of norms, rules and guidelines to ensure consistency and accuracy of laboratory results.

22 Сен 2020

LETTER CALENDAR: ROUNDING OFF OUR BRIEF INSIGHT INTO THE HISTORY OF GMP RULES IN RUSSIA

This Friday we round off our brief insight into the history of GMP Rules in Russia and recollect the key events of the past decade.

22 Сен 2020

НЕПРЕРЫВНОЕ ПРОИЗВОДСТВО В НАСТОЯЩЕМ И БУДУЩЕМ

Быстрые изменения, которые происходят в мире, а также развитие технологий, требуют внедрения новых подходов в фармацевтической промышленности, один из которых – непрерывное производство (НП). Эта система позволяет ускорить разработку, снизить…

22 Сен 2020

GMP INSPECTION: NEW FORMATS, SAME GOALS

THE COVID-19 PANDEMIC HAS TRIGGERED A NUMBER OF SERIOUS CHANGES IN THE PHARMACEUTICAL INDUSTRY, INCLUDING REGULATION AND INSPECTION OF DRUG MANUFACTURING. Given the restrictions related to free travel and conduction…

22 Сен 2020

INFORMATION SUPPORT AS AN ESSENTIAL ELEMENT OF PRESENT-DAY EVENTS TARGETING THE PROFESSIONAL COMMUNITY

For the fifth year now, the All-Russia GMP Conference has been actively partnering the leading mass media specialising in pharmaceutics, medicine, and GMP practices.

22 Сен 2020

LETTER CALENDAR: ON SATURDAY WE PLACE OUR FOCUS ON ROSZDRAVNADZOR’S NEW RECOMMENDATIONS REGARDING THE USE OF THE MDLP SYSTEM BY THE PHARMACEUTICAL INDUSTRY

On Saturday we place our focus on Roszdravnadzor’s new recommendations regarding the use of the MDLP system by the pharmaceutical industry. The document which offers clarifications on six cases that…

22 Сен 2020

LETTER CALENDAR: ON SUNDAY LET’S TURN TO THE ISSUE OF IDENTIFYING IMPURITIES IN FINISHED DOSAGE FORMS (FDF)

This is the name of the topic to be discussed at the Vth All-Russia GMP Conference at the panel discussion on the “Potential of Local API Manufacturing and Current Local…

22 Сен 2020

LETTER CALENDAR: RE-ADDRESSING THE IMPORTANT ISSUE OF VACCINE PRODUCTION

For the autumn and winter season of 2020-2021, the federal budget allocated RUB 22.5 bln for the procurement of vaccines. However, last week, on September 11, Prime Minister of the…

НОВОСТИ

NOVARTIS IS A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

AKRIKHIN TO PARTNER THE VI ALL-RUSSIAN GMP CONFERENCE 2021

PRO.MED.CS PRAHA A.S. TO SUPPORT A SESSION DEDICATED TO THE CIRCULATION OF PHARMACEUTICALS IN THE EAEU

ABBOTT WILL SUPPORT THE PANEL DISCUSSION “INTERDISCIPLINARY APPROACH TO GOOD PRACTICES REGULATION”.

TEVA TO SHARE ITS PHARMACEUTICAL QUALITY AND SAFETY EXPERT REVIEW

AMGEN. OUR MISSION: TO SERVE PATIENTS

PHARMECO GROUP OF COMPANIES IS A SPECIAL PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

NOVO NORDISK BECOMES A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION

GEDEON RICHTER STARTS PRODUCING IN RUSSIA AN INNOVATIVE DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER

GMP CONFERENCE ORGANIZERS EXPECTING TO RECEIVE QUESTIONS FROM PHARMACEUTICAL INDUSTRY REPRESENTATIVES RELATED TO TECHNOLOGY TRANSFER

LETTER CALENDAR: NEWS OF THE PARTNERS OF THE ALL-RUSSIA GMP CONFERENCE

GLP: TOP QUALITY OF NONCLINICAL STUDIES

LETTER CALENDAR: ROUNDING OFF OUR BRIEF INSIGHT INTO THE HISTORY OF GMP RULES IN RUSSIA

НЕПРЕРЫВНОЕ ПРОИЗВОДСТВО В НАСТОЯЩЕМ И БУДУЩЕМ

GMP INSPECTION: NEW FORMATS, SAME GOALS

INFORMATION SUPPORT AS AN ESSENTIAL ELEMENT OF PRESENT-DAY EVENTS TARGETING THE PROFESSIONAL COMMUNITY

LETTER CALENDAR: ON SATURDAY WE PLACE OUR FOCUS ON ROSZDRAVNADZOR’S NEW RECOMMENDATIONS REGARDING THE USE OF THE MDLP SYSTEM BY THE PHARMACEUTICAL INDUSTRY

LETTER CALENDAR: ON SUNDAY LET’S TURN TO THE ISSUE OF IDENTIFYING IMPURITIES IN FINISHED DOSAGE FORMS (FDF)

LETTER CALENDAR: RE-ADDRESSING THE IMPORTANT ISSUE OF VACCINE PRODUCTION

УЧАСТНИКАМ

СМИ

ПАРТНЕРЫ

+7 (495) 120-53-33